Mgame Corp. CEO Kwon Yi-hyung and Executive Vice President Jo In-han Each Purchase 50 Million Won Worth of Company Stock
"Strengthening Corporate Governance, Enhancing Shareholder Value"
Registered Executives Continue to Buy Company Stock
First Quarterly Dividend Since Inception
[Edaily Reporter An Yu-ri ] Mgame Corp.(058630)announced on the 26th that CEO Kwon Yi-hyung and Executive Vice President Jo In-han each purchased 50 million won worth of company stock to strengthen responsible management and enhance shareholder value.
Mgame Corp. Reports First-Quarter Revenue of 24.2 Billion Won and Operating Profit of 3.2 Billion Won
According to the regulatory filing, CEO Kwon Yi-hyung purchased 12,105 shares and Executive Vice President Jo In-han purchased 11,694 shares on the open market. The purchase amount was 50 million won for each executive.
Following earlier purchases by Executive Vice President Hong Deung-ho and Director Lee Jae-chang, other members of Mgame Corp.’s management are now joining the trend of buying company stock.
The company emphasized that this decision reflects management’s commitment to enhancing corporate value and their confidence in the company’s sustainable growth potential.
Mgame Corp. has paid cash dividends annually since 2023 and distributed 222 won per share as part of the final dividend for the 2025 fiscal year. In addition, the company decided to implement quarterly dividends for the first time since its founding and filed a disclosure setting the record date. Specific details, such as the exact dividend amount, will be announced following a board resolution.
Furthermore, Mgame Corp. repurchased 2 billion won worth of its own shares this year and plans to cancel all of them to enhance shareholder value.
Furthermore, during the third quarter of this year, the company plans to diversify its lineup by launching pre-registration for “Raising Ghosts,” an idle mobile game based on the popular IP “Ghost,” reopening a PC MMORPG based on the legacy IP “Wind, Forest, Fire, Mountain,” and introducing one new mobile publishing title.
(Photo: Blind)
One of the concerns facing the Lee Jae-myung administration is the decline in support among young people. According to Gallup Korea’s presidential job approval ratings, the approval…
The KRX Health Care Index rose 4.53% from the previous session on Oct. 1, signaling a rare tailwind for South Korea’s pharmaceutical and biotech sector. Among the gainers, GIInnovation and G2GBio drew…
(Graphic: ChatGPT)
“While existing ex vivo chimeric antigen receptor T-cell (CAR-T) therapies are personalized treatments that require cell collection from each patient for manufacturing, the in v…